These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 39343249)
1. Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment. Liu J; Ji Z; He Q; Chen H; Xu X; Mei Q; Hu Y; Zhang H Neurobiol Dis; 2024 Oct; 201():106683. PubMed ID: 39343249 [TBL] [Abstract][Full Text] [Related]
2. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation. Jiang Z; Wang J; Sun G; Feng M Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967 [TBL] [Abstract][Full Text] [Related]
3. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes. Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447 [TBL] [Abstract][Full Text] [Related]
4. The Extracts of Human Fetal Brain Induce the Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Dopaminergic Neuron Containing Cells. Li Y; Yang J; Li M; Zhang X; Du J; Zhao X; Xu Z; Lin J Cell Reprogram; 2020 Oct; 22(5):254-261. PubMed ID: 32833524 [TBL] [Abstract][Full Text] [Related]
6. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model. Yan M; Sun M; Zhou Y; Wang W; He Z; Tang D; Lu S; Wang X; Li S; Wang W; Li H PLoS One; 2013; 8(5):e64000. PubMed ID: 23724014 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons. Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268 [TBL] [Abstract][Full Text] [Related]
8. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Xiong N; Zhang Z; Huang J; Chen C; Zhang Z; Jia M; Xiong J; Liu X; Wang F; Cao X; Liang Z; Sun S; Lin Z; Wang T Gene Ther; 2011 Apr; 18(4):394-402. PubMed ID: 21107440 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model. Chi H; Guan Y; Li F; Chen Z Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Parkinson's disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF. Wang CC; Hu XM; Long YF; Huang HR; He Y; Xu ZR; Qi ZQ Life Sci; 2024 Nov; 356():123014. PubMed ID: 39182566 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic Induction of Umbilical Cord Mesenchymal Stem Cells by Conditioned Medium of Choroid Plexus Epithelial Cells Reduces Apomorphine-Induced Rotation in Parkinsonian Rats. Aliaghaei A; Gardaneh M; Maghsoudi N; Salehinejad P; Gharib E Arch Iran Med; 2016 Aug; 19(8):561-70. PubMed ID: 27544365 [TBL] [Abstract][Full Text] [Related]
12. Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease. Li Y; Li Z; Gu J; Xu X; Chen H; Gui Y Neurosci Lett; 2022 Feb; 771():136414. PubMed ID: 34954117 [TBL] [Abstract][Full Text] [Related]
13. Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis. Lian C; Huang Q; Zhong X; He Z; Liu B; Zeng H; Xu N; Yang Z; Liao C; Fu Z; Guo H FASEB J; 2021 Jul; 35(7):e21748. PubMed ID: 34152016 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease. Alexanian AR; Sorokin A; Duersteler M J Neurol Sci; 2024 Oct; 465():123188. PubMed ID: 39178824 [TBL] [Abstract][Full Text] [Related]
15. Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons. Zhang L; Yang H Neurosci Lett; 2021 Jan; 742():135520. PubMed ID: 33246026 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease. Venkatesh K; Sen D Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480 [TBL] [Abstract][Full Text] [Related]
17. The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells. Wang N; Ji X; Wu Y; Zhou S; Peng H; Wang J; Yu S; Zhang J Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830023 [TBL] [Abstract][Full Text] [Related]
18. Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model. Shetty P; Thakur AM; Viswanathan C Cell Biol Int; 2013 Feb; 37(2):167-80. PubMed ID: 23339105 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model. Park H; Chang KA Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234 [TBL] [Abstract][Full Text] [Related]